%PDF-1.4
1 0 obj
<< /Type /Catalog /Pages 2 0 R >>
endobj
2 0 obj
<< /Type /Pages /Kids [3 0 R] /Count 1 >>
endobj
3 0 obj
<< /Type /Page /Parent 2 0 R /MediaBox [0 0 612 792] /Contents 4 0 R /Resources << /Font << /F1 5 0 R >> >> >>
endobj
4 0 obj
<< /Length 850 >>
stream
BT
/F1 24 Tf
50 750 Td
(Pharmaceutical Market Analysis Report) Tj
0 -40 Td
/F1 14 Tf
(Executive Summary) Tj
0 -25 Td
/F1 11 Tf
(This report provides comprehensive analysis of the pharmaceutical) Tj
0 -15 Td
(market landscape, including clinical trial pipelines, competitive) Tj
0 -15 Td
(intelligence, and market opportunities.) Tj
0 -30 Td
/F1 14 Tf
(Key Market Insights:) Tj
0 -20 Td
/F1 11 Tf
(- Global pharmaceutical market valued at USD 1.48 trillion in 2024) Tj
0 -15 Td
(- Oncology segment leads with 27% market share) Tj
0 -15 Td
(- Biologics growing at 8.2% CAGR) Tj
0 -15 Td
(- Gene therapy market expected to reach USD 35B by 2028) Tj
0 -30 Td
/F1 14 Tf
(Clinical Trial Pipeline:) Tj
0 -20 Td
/F1 11 Tf
(- 6,500+ active Phase 3 trials globally) Tj
0 -15 Td
(- Immunotherapy trials increased 45% YoY) Tj
0 -15 Td
(- Average Phase 3 duration: 36 months) Tj
ET
endstream
endobj
5 0 obj
<< /Type /Font /Subtype /Type1 /BaseFont /Helvetica >>
endobj
xref
0 6
0000000000 65535 f 
0000000009 00000 n 
0000000058 00000 n 
0000000115 00000 n 
0000000266 00000 n 
0000001168 00000 n 
trailer
<< /Size 6 /Root 1 0 R >>
startxref
1247
%%EOF